Every earlier piece in this series follows the supply: the consent gaps, the brokers in court, the bodies obtained one way and used another. But supply does not move without demand. There is a market on the other side — legitimate, well-funded, and for non-transplant bodies almost entirely lawful. This is a sourced look at who pays for the dead, and why it is allowed, drawn from OrganWatch. It names buyers and businesses, never a donor or an individual.
The buyers
The customers are not shadowy. Medical-device manufacturersrun cadaver labs to develop and demonstrate products — implants, instruments, surgical systems — a routine, legal part of device R&D and physician training. Surgical specialty societies and training conferences buy specimens for hands-on courses. Universities and research programs acquire bodies for anatomy and study. And the buyer that most unsettles on the page is the US military: court and investigative records document donated bodies acquired, through brokers, for blast, IED, and landmine survivability testing — including bodies that families had donated believing they were destined for medical research.
A market with a price list
Because the demand is real, a market formed, with prices. A 2017 investigative series documented a per-part economy in which a single donated body is worth more disassembled than whole — torsos, spines, heads, and limbs each carrying their own price — and reported that, over years, on the order of 50,000 donated bodies and 180,000-plus body parts moved through the non-transplant trade. The same reporting showed how few barriers exist: its reporters were able to legally buy two human heads and a spinefrom a broker for roughly $900 plus shipping. One for-profit broker in this record turned free donations into about $27 million in annual revenue. The donor pays nothing and is paid nothing; everyone between the bedside and the lab bench can be.
Why it is legal
The reason traces to a single line in federal law. The National Organ Transplant Act bars selling a human organ for transplantation — but says nothing about whole bodies or tissue donated for research, education, or device testing. Those can be transferred for “reasonable” fees with almost no federal floor: no licensing regime, no registry, no consent standard comparable to the tightly governed transplant system. The result is a lawful commercial market sitting directly on top of the weakest consent protections in American law. The demand is legitimate; the supply chain that feeds it is the one with the holes.
What the demand pulls on
That is the uncomfortable join. A device company's need for a knee, a training course's need for a head, the military's need for a torso — each is a legitimate use, and each creates a pull on supply. The supply most cheaply available is the body with the least protection: the unclaimed, the indigent, the family told one thing while another happened. The same money logic that runs through the tissue economy runs here too — a free gift at one end, a paid product at the other, and the least-protected people supplying the difference.
What this record is
Every buyer, business, and figure here is documented in court records, federal cases, or major published investigations, source-linked in OrganWatch. It names companies, institutions, and categories of buyer — never a donor, a family, or a private individual. The legitimate demand is not the scandal; the scandal is a multi-tens-of- millions market built on a supply chain the law barely watches.
The data: OrganWatch — the deep-investigation, prosecutions, and follow-the-money records behind this piece.
The series: which OPOs are failing, the body trade in court, the consent gap, the 50-state map, the money, the bedside, and the monopoly.